Abstract |
In vitro NK responses of cancer patients (N = 21) to rIFN-alpha A and rIL-2 were examined. The serum concentration of IAP ( immunosuppressive acidic protein) was determined in parallel. Five out of seven patients whose serum IAP contents were within the normal range (270 micrograms/ml to 470 micrograms/ml), had their NK activities significantly augmented by rIFN-alpha A and rIL-2. On the other hand, NK cells from ten out of fifteen patients whose serum IAP concentrations were 650 micrograms/ml or more, were not activated by rIFN-alpha A. NK cells of these fifteen patients yet were capable of responding to rIL-2. NK cells from cancer patients, however, became responsive to rIFN-alpha A by either removal of adherent cells or treatment with indomethacin. Therefore, macrophages in PBMC of cancer patients with high serum IAP levels seem to selectively suppress NK response to rIFN-alpha A by an indomethacin-sensitive mechanisms. It was further shown that PGE2 was not the mediator of this suppression.
|
Authors | H Aso, K Tamura, O Yoshie, T Nakamura, S Kikuchi, N Ishida |
Journal | Microbiology and immunology
(Microbiol Immunol)
Vol. 36
Issue 10
Pg. 1087-97
( 1992)
ISSN: 0385-5600 [Print] Australia |
PMID | 1479963
(Publication Type: Journal Article)
|
Chemical References |
- Interferon Type I
- Interleukin-2
- Neoplasm Proteins
- Recombinant Proteins
- immunosuppressive acidic protein
- Dinoprostone
- Indomethacin
|
Topics |
- Adult
- Cytotoxicity, Immunologic
(immunology)
- Dinoprostone
(biosynthesis)
- Humans
- Indomethacin
(pharmacology)
- Interferon Type I
(pharmacology)
- Interleukin-2
(pharmacology)
- Killer Cells, Natural
(drug effects, immunology)
- Lymphocyte Activation
(immunology)
- Macrophages
(physiology)
- Monocytes
(immunology)
- Neoplasm Proteins
(blood)
- Neoplasms
(blood, immunology)
- Recombinant Proteins
(pharmacology)
- Tumor Cells, Cultured
|